These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1151541)

  • 21. A review of paralytic poliomyelitis cases occurring after polio vaccination.
    Basu SN
    J Indian Med Assoc; 1986 Jul; 84(7):203-6. PubMed ID: 3794352
    [No Abstract]   [Full Text] [Related]  

  • 22. Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia.
    Wright PF; Hatch MH; Kasselberg AG; Lowry SP; Wadlington WB; Karzon DT
    J Pediatr; 1977 Sep; 91(3):408-12. PubMed ID: 197220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonparalytic poliovirus infections in patients with severe combined immunodeficiency disease.
    Lopez C; Biggar WD; Park BH; Good RA
    J Pediatr; 1974 Apr; 84(4):497-502. PubMed ID: 4151810
    [No Abstract]   [Full Text] [Related]  

  • 24. [Characterization of the immune status of patients with vaccine-associated poliomyelitis].
    Ermolovich MA; Fel'dman EV; Samoĭlovich EO; Kuzovkova NA; Levin VI
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (2):42-50. PubMed ID: 12043152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine-associated poliomyelitis in a child with thymic abnormality.
    Riker JB; Brandt CD; Chandra R; Arrobio JO; Nakano JH
    Pediatrics; 1971 Dec; 48(6):923-9. PubMed ID: 4331606
    [No Abstract]   [Full Text] [Related]  

  • 26. [On 2 cases of acute anterior poliomyelitis in vaccinated subjects, with immunological deficiency syndrome].
    Monacelli M; Balbo G; D'Amato C
    G Mal Infett Parassit; 1970 Jun; 22(6):363-4. PubMed ID: 5459581
    [No Abstract]   [Full Text] [Related]  

  • 27. Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child.
    Hidalgo S; García Erro M; Cisterna D; Freire MC
    Pediatr Infect Dis J; 2003 Jun; 22(6):570-2. PubMed ID: 12828159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine-derived polioviruses--update.
    Wkly Epidemiol Rec; 2006 Oct; 81(42):398-404. PubMed ID: 17066552
    [No Abstract]   [Full Text] [Related]  

  • 30. Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India.
    Mohanty MC; Madkaikar MR; Desai M; Taur P; Nalavade UP; Sharma DK; Gupta M; Dalvi A; Shabrish S; Kulkarni M; Aluri J; Deshpande JM
    Emerg Infect Dis; 2017 Oct; 23(10):1664-1670. PubMed ID: 28930011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possibility of diseases affecting the central nervous system caused by vaccine strains of poliovirus, type 3].
    Golub NF; Bogdanov IL; Vashchenko MA
    Zh Mikrobiol Epidemiol Immunobiol; 1972 May; 49(5):134-6. PubMed ID: 5037754
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical and electroencephalographic studies of subjects with the West syndrome appearing after poliomyelitis vaccination].
    Marchesi GF; Quattrini A
    Riv Neurol; 1976; 46(5):377-82. PubMed ID: 1025680
    [No Abstract]   [Full Text] [Related]  

  • 33. New recommendations for poliovirus vaccination. Combination regimen captures best effects of available vaccines.
    Conrad DA; Jenson HB
    Postgrad Med; 1997 Nov; 102(5):45-8, 51-3, 59-60 passim. PubMed ID: 9385331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paralysis case and contact spread of recombinant vaccine-derived poliovirus, Spain.
    Avellón A; Cabrerizo M; de Miguel T; Pérez-Breña P; Tenorio A; Pérez JL; de Aragón MV; Trallero G
    Emerg Infect Dis; 2008 Nov; 14(11):1807-9. PubMed ID: 18976579
    [No Abstract]   [Full Text] [Related]  

  • 35. [Vaccine poliomyelitis as a complication of oral vaccination].
    Kruppenbacher JP; Mertens T; Adrian M; Smolenski S; Leidel J; Eggers HJ
    Offentl Gesundheitswes; 1983 Oct; 45(10):528-31. PubMed ID: 6227849
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984.
    Nkowane BM; Wassilak SG; Orenstein WA; Bart KJ; Schonberger LB; Hinman AR; Kew OM
    JAMA; 1987 Mar; 257(10):1335-40. PubMed ID: 3029445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poliomyelitis from a vaccine.
    Kitamura I; Hirai S; Kurashige T
    Lancet; 1969 Mar; 1(7592):465. PubMed ID: 4179522
    [No Abstract]   [Full Text] [Related]  

  • 39. [On convulsive reactions following oral vaccination against polio (author's transl)].
    Ehrengut W; Ehrengut-Lange J
    Klin Padiatr; 1979 May; 191(3):261-70. PubMed ID: 572444
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety aspects of oral poliovirus vaccine campaigns.
    Hovi T
    Dev Biol Stand; 1995; 84():137-44. PubMed ID: 7796946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.